TriangleNCT00128921 · OUTCOME
Number of Participants With a Positive Response to Bortezomib Measured by Bone Marker Alkaline Phosphatase
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- participants
- Interval / dispersion
- Not reported
- Time frame
- 6 months
What was measured
Alkaline phosphatase: If the Alkaline phosphatase increases it's considered positive response
Groups in this outcome
Cohort A
Cohort A: Received bortezomib 1.3 mg/m2 per days 1, 4, 8 and 11.
Cohort B
Cohort B: Received bortezomib 1.0 mg/m2 per days 1, 4, 8 and 11.
| Group | Source count |
|---|---|
| Cohort A | 10 |
| Cohort B | 6 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Cohort A | 4 | Not reported | 4.5 | 48.4 | Not reported |
| Cohort B | 3 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- lower Limit
- 4.5
- upper Limit
- 48.4
- value
- 4
- group Id
- OG001
- value
- 3
- denoms
- counts
- group Id
- OG000
- value
- 10
- group Id
- OG001
- value
- 6
- units
- Participants
- description
- Alkaline phosphatase: If the Alkaline phosphatase increases it's considered positive response
- groups
- description
- Cohort A: Received bortezomib 1.3 mg/m2 per days 1, 4, 8 and 11.
- id
- OG000
- title
- Cohort A
- description
- Cohort B: Received bortezomib 1.0 mg/m2 per days 1, 4, 8 and 11.
- id
- OG001
- title
- Cohort B
- param Type
- NUMBER
- reporting Status
- POSTED
- time Frame
- 6 months
- title
- Number of Participants With a Positive Response to Bortezomib Measured by Bone Marker Alkaline Phosphatase
- type
- PRIMARY
- unit Of Measure
- participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice